Related Experiment Videos
Bis[3,6-bis(6-methyl-2pyridyl)pyridazine-kappa2N2,N3]chlorocopper(II) perchlorate
1Department of Cultural Heritage Conservation Science, Kongju National University, Kongju 314-701, Korea.
Acta Crystallographica. Section C, Crystal Structure Communications
|February 15, 2001
Summary
This study details a novel copper(II) complex with a trigonal bipyramidal geometry. The complex features a unique coordination environment involving chloride and pyridazine ligands, offering insights into coordination chemistry.
Area of Science:
- Inorganic Chemistry
- Coordination Chemistry
- Crystallography
Background:
- Copper(II) complexes are crucial in various catalytic and biological processes.
- Understanding coordination geometries is key to predicting complex reactivity and properties.
- Pyridazine-based ligands offer unique electronic and steric properties for metal coordination.
Purpose of the Study:
- To synthesize and characterize a novel copper(II) complex with pyridazine ligands.
- To elucidate the coordination geometry and electronic structure of the copper(II) ion.
- To investigate the structural features of the [CuCl(C16H14N4)2]ClO4 complex.
Main Methods:
- Synthesis of the title compound, [CuCl(C16H14N4)2]ClO4.
- Single-crystal X-ray diffraction analysis to determine the molecular structure.
- Spectroscopic characterization (e.g., UV-Vis, IR) to confirm composition and bonding.
Main Results:
- The crystal structure reveals a mononuclear copper(II) complex cation and a perchlorate anion.
- The copper(II) ion adopts a trigonal bipyramidal coordination geometry.
- The equatorial plane consists of a chloride atom and two nitrogen atoms from pyridazine rings, while axial positions are occupied by nitrogen atoms from methylpyridine rings.
Conclusions:
- The study successfully synthesized and structurally characterized a novel copper(II) complex.
- The trigonal bipyramidal geometry around the copper(II) center is confirmed.
- The findings contribute to the understanding of copper coordination chemistry with N-heterocyclic ligands.